A development and validation of predictive model based on novel immune-related gene-based subtypes for the risk assessment of cutaneous melanoma
CM was divided into two subtypes based on immune gene expression, with the C1 subtype associated with poor prognosis. A prognostic risk model was developed using these classifications to predict patient outcomes.
Authors
- Chengyu Sui
- Bin Liang (ORCID: https://orcid.org/0000-0002-6130-8629)
- Xinji Li (ORCID: https://orcid.org/0000-0001-9748-1565)
- Tianhui Niu
- Zhiwei Hao (ORCID: https://orcid.org/0009-0004-0124-6931)
- Fei Li (ORCID: https://orcid.org/0009-0006-1479-2821)
- Zhiyong Wang (ORCID: https://orcid.org/0000-0003-4602-3390)
- Xiaoxin Li (ORCID: https://orcid.org/0000-0002-5161-9458)
- Ling Guan (ORCID: https://orcid.org/0000-0002-3120-8221)
- Yuanyuan Li (ORCID: https://orcid.org/0009-0000-8557-5716)
Institutions
- United States Air Force (US)
- Air Force General Hospital PLA (CN)
- Maternal and Child Health Hospital of Xuzhou (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-08-01
- DOI
- https://doi.org/10.21037/tcr-2025-954
- Citations
- 1
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.05